| Particulars |
|
|
|
| Company Name
| Transgene Biotek Ltd
| Year End
| 202503
|
| Full Year |
| Equity (₹ Cr.) |
75.77 |
B.V. (₹) |
-1.00 |
| Sales(₹ Cr.) |
0.26 |
NP (₹ Cr.) |
-0.68 |
| NP Var% |
-3.00 |
Div% |
0.00 |
| CPS(₹) |
-0.10 |
EPS (₹) |
-0.10 |
| Traded Value(₹ Lakhs) |
0.95 |
52 Week High |
8.00 |
| 52 Week Low |
3.00 |
Price BSE |
4.00 |
| Price NSE |
0.00 |
Market Capital (₹ Cr.) |
28.79 |
| P/C Ratio |
-52.00 |
P/E Ratio |
-44.80 |
| Price Vs.BV |
-4.00 |
|
| Latest Quarter |
| Year End |
202506 |
Sales (₹ Cr.) |
0.05 |
| NP(₹ Cr.) |
-0.43 |
NP Var % |
-318.00 |
| Trailing Twelve Months |
| Year End |
202506 |
Sales |
0.20 |
| OPM |
-437.13 |
NP |
-0.27 |
| NP Var% |
-303.33 |
EPS |
0.00 |
| PE |
0.00 |
|
|